LakeShore Biopharma Co., Ltd (LSB)
USD 1.76
(4.14%)
USD 1.76
(4.14%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 901.56 Million CNY | 11.79% |
| 2022 | 647.15 Million CNY | 117739.66% |
| 2021 | 549.17 Thousand CNY | -99.83% |
| 2020 | 319.67 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q4 | 29.81 Million USD | -3.1% |
| 2023 FY | 723.43 Million CNY | 11.79% |
| 2023 Q3 | 30.76 Million USD | -82.85% |
| 2023 Q2 | 179.36 Million CNY | -14.66% |
| 2023 Q1 | 210.17 Million CNY | 811.74% |
| 2022 Q3 | 32.54 Million USD | 33.76% |
| 2022 Q1 | 410.66 Thousand USD | 75.72% |
| 2022 Q2 | 24.33 Million USD | 5824.72% |
| 2022 FY | 647.15 Million CNY | 117739.66% |
| 2022 Q4 | 23.05 Million USD | -29.17% |
| 2021 Q1 | 40.32 Thousand USD | 0.0% |
| 2021 FY | 549.17 Thousand CNY | -99.83% |
| 2021 Q4 | 233.7 Thousand USD | -22.69% |
| 2021 Q3 | 302.31 Thousand USD | 48.99% |
| 2021 Q2 | 202.9 Thousand USD | 403.13% |
| 2020 FY | 319.67 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Agenus Inc. | 78.18 Million USD | -1053.144% |
| Immix Biopharma, Inc. | 16.14 Million USD | -5485.504% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -432.596% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -498.902% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -136.944% |
| MiMedx Group, Inc. | 229.72 Million USD | -292.449% |
| Novavax, Inc. | 779.12 Million USD | -15.715% |
| Seer, Inc. | 110.49 Million USD | -715.967% |
| Acelyrin, Inc. | 422.06 Million USD | -113.608% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -435.255% |
| IO Biotech, Inc. | 91.44 Million USD | -885.928% |
| Ardelyx, Inc. | 169.93 Million USD | -430.527% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -464.228% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -6381.565% |
| Fortress Biotech, Inc. | 200.19 Million USD | -350.342% |
| Fortress Biotech, Inc. | 200.19 Million USD | -350.342% |
| Geron Corporation | 70.44 Million USD | -1179.883% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -102.263% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -2653.199% |
| Incyte Corporation | 1.19 Billion USD | 24.27% |
| Innoviva, Inc. | 132.15 Million USD | -582.206% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -10568.116% |
| ChromaDex Corporation | 56.37 Million USD | -1499.11% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -969.177% |
| MEI Pharma, Inc. | 34.78 Million USD | -2491.814% |
| NextCure, Inc. | 67.63 Million USD | -1232.943% |
| Onconetix, Inc. | 34.9 Million USD | -2482.724% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -6973.297% |
| GlycoMimetics, Inc. | 39.28 Million USD | -2194.911% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -471.282% |
| Vaxcyte, Inc. | 468.04 Million USD | -92.625% |
| Precigen, Inc. | 84.18 Million USD | -970.981% |
| Pharming Group N.V. | 225.49 Million USD | -299.822% |
| ContextLogic Inc. | 387 Million USD | -132.962% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -4662.864% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -996.845% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -592.109% |
| AlloVir, Inc. | 180.93 Million USD | -398.285% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3609.125% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -461.581% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -6992008.399% |
| Summit Therapeutics Inc. | 87.68 Million USD | -928.171% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -292.062% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -2332.448% |
| Senti Biosciences, Inc. | 94.7 Million USD | -851.969% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -424.463% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2959.359% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -582.098% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -32665.205% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1597.015% |
| Chimerix, Inc. | 93.38 Million USD | -865.384% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1994.454% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -5064.475% |
| CRISPR Therapeutics AG | 463.49 Million USD | -94.514% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -397.274% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -437.198% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -1142.403% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -832.233% |
| Precision BioSciences, Inc. | 92.46 Million USD | -875.052% |
| Dyadic International, Inc. | 9.15 Million USD | -9750.239% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1883.854% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -3951.42% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -348.282% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 49.915% |
| Aptorum Group Limited | 10.56 Thousand USD | -8532575.156% |
| Bicycle Therapeutics plc | 216.92 Million USD | -315.616% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -22770.408% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -2655.808% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -13292.305% |
| GT Biopharma, Inc. | 13.57 Million USD | -6540.855% |
| Alkermes plc | 996.24 Million USD | 9.504% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -1177.109% |
| Jaguar Health, Inc. | 42.01 Million USD | -2045.811% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -2545.042% |
| AbCellera Biologics Inc. | 275.23 Million USD | -227.565% |
| PureTech Health plc | 144.59 Million USD | -523.5% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -4542.798% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -294.246% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -2280.74% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -964.217% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3609.125% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -864.465% |
| AnaptysBio, Inc. | 181.56 Million USD | -396.543% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -2563.877% |
| ESSA Pharma Inc. | 32.13 Million USD | -2705.625% |
| Molecular Templates, Inc. | 63.09 Million USD | -1328.987% |
| Scopus BioPharma Inc. | 11.71 Million USD | -7595.876% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -123.401% |
| Vaxxinity, Inc. | 56.05 Million USD | -1508.468% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -1678.475% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2821.554% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -1012.189% |
| Structure Therapeutics Inc. | 102.77 Million USD | -777.22% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1488.404% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -629.697% |
| ImmuCell Corporation | 9.61 Million USD | -9274.322% |
| Lantern Pharma Inc. | 17.87 Million USD | -4942.981% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2937.405% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2945.202% |
| Opthea Limited | 191.96 Million USD | -369.644% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -267.748% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2829.91% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -254.884% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -310.118% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -247.523% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1567.09% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -8972.194% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -247.21% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1621.985% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -6156.343% |
| Soligenix, Inc. | 7.79 Million USD | -11465.535% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1507.894% |
| Kura Oncology, Inc. | 165.8 Million USD | -443.752% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -687.343% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -10737.39% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -36229.315% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -737.121% |
| Autolus Therapeutics plc | 196.72 Million USD | -358.283% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -964.959% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -674.186% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -4551.305% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -180.199% |
| GRI Bio, Inc. | 11.33 Million USD | -7857.303% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -12677.787% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -587.203% |
| IGM Biosciences, Inc. | 265.59 Million USD | -239.455% |
| INmune Bio, Inc. | 29.89 Million USD | -2915.662% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -422.481% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2136.334% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -5542.043% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -5627.278% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -1351.838% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -738.491% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -227.017% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -199.074% |
| Verastem, Inc. | 92.08 Million USD | -879.065% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -4925.712% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -385.429% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -642.595% |
| Histogen Inc. | 14.27 Million USD | -6217.002% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -5517.862% |
| Surrozen, Inc. | 18.55 Million USD | -4760.175% |
| Organovo Holdings, Inc. | 14.91 Million USD | -5944.67% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -17611.604% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1410.834% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -3415.275% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1817.973% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -11711.621% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -406.109% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1760.889% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -267.979% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -5767.036% |
| Apollomics, Inc. | 54.14 Million USD | -1565.243% |
| Amarin Corporation plc | 272.35 Million USD | -231.022% |
| Mesoblast Limited | 5.9 Million USD | -15175.541% |
| Turnstone Biologics Corp. | 78.33 Million USD | -1050.862% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -269.308% |
| Synaptogenix, Inc. | 8.31 Million USD | -10744.098% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -6081.012% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -256.27% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -2604.952% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -10108.793% |
| Exelixis, Inc. | 1.58 Billion USD | 43.183% |
| Better Therapeutics, Inc. | 38.26 Million USD | -2256.287% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -288.521% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -5.421% |
| NLS Pharmaceutics AG | 11.8 Million USD | -7535.789% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -11110.806% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -2905.91% |
| Gritstone bio, Inc. | 148.37 Million USD | -507.628% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1209.25% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -5410.7% |
| Avid Bioservices, Inc. | 25.99 Million USD | -3368.081% |
| Insmed Incorporated | 949.26 Million USD | 5.025% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -5646.174% |
| MediWound Ltd. | 18.86 Million USD | -4678.262% |
| OmniAb, Inc. | 83.89 Million USD | -974.632% |
| Alector, Inc. | 248.8 Million USD | -262.361% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -284.777% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1625.445% |
| Zai Lab Limited | 547.47 Million USD | -64.676% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -126.152% |
| Aura Biosciences, Inc. | 84.99 Million USD | -960.774% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -264.801% |
| Immunic, Inc. | 99.22 Million USD | -808.622% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -466.978% |
| Veracyte, Inc. | 357.93 Million USD | -151.88% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 90.0% |
| FibroGen, Inc. | 398.11 Million USD | -126.459% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -6244.563% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -12988.987% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -12552.208% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 72.308% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -3384.569% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -184.815% |
| TG Therapeutics, Inc. | 198.47 Million USD | -354.245% |
| Galecto, Inc. | 35.62 Million USD | -2430.56% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -2115.74% |
| Fortrea Holdings Inc. | 457.3 Million USD | -97.149% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1561.009% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -3021.97% |
| XBiotech Inc. | 37.51 Million USD | -2303.526% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1209.25% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -4266.131% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -534.631% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -809.98% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -714.302% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 5.916% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -3025.542% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -109.354% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -3941.374% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -713.193% |
| NexImmune, Inc. | 28.16 Million USD | -3100.718% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -16200.324% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -4938.77% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 67.976% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -3441.233% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -609.545% |
| Ainos, Inc. | 12.95 Million USD | -6860.441% |
| Pluri Inc. | 22.48 Million USD | -3910.509% |
| Prothena Corporation plc | 282.4 Million USD | -219.243% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -350.732% |
| Celularity Inc. | 215.05 Million USD | -319.218% |
| Rallybio Corporation | 78.93 Million USD | -1042.201% |
| Cue Biopharma, Inc. | 19.54 Million USD | -4513.461% |
| MeiraGTx Holdings plc | 151.07 Million USD | -496.753% |
| Omeros Corporation | 94.75 Million USD | -851.507% |
| Humacyte, Inc. | 23.49 Million USD | -3736.926% |
| Immunocore Holdings plc | 308.04 Million USD | -192.677% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -26494.763% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -937.889% |
| Blueprint Medicines Corporation | 722.86 Million USD | -24.721% |
| CalciMedica, Inc. | 21.81 Million USD | -4032.385% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1107.558% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -426.322% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -205.677% |
| Pulmatrix, Inc. | 22.03 Million USD | -3990.945% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -2507.556% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -914.519% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -63.455% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -1142.66% |
| Cytokinetics, Incorporated | 173.61 Million USD | -419.297% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -2519.374% |
| Nutriband Inc. | 5.73 Million USD | -15623.013% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1967.187% |
| Vor Biopharma Inc. | 126.03 Million USD | -615.321% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 24.186% |
| Evogene Ltd. | 27.79 Million USD | -3144.197% |
| ProKidney Corp. | 151.52 Million USD | -495.004% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1115.453% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -11620.412% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -46.78% |
| CorMedix Inc. | 48.95 Million USD | -1741.51% |
| BioLineRx Ltd. | 50.8 Million USD | -1674.659% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -498.25% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -2268.046% |
| Atai Life Sciences N.V. | 125.78 Million USD | -616.749% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -1004.324% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -1007.448% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -256.981% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -2653.703% |
| MediciNova, Inc. | 10.9 Million USD | -8171.014% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -599.862% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -12319.03% |
| GeoVax Labs, Inc. | 6.02 Million USD | -14870.717% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -89.261% |
| Biomea Fusion, Inc. | 126.13 Million USD | -614.76% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 31.275% |
| Mereo BioPharma Group plc | 35.84 Million USD | -2415.38% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -371.802% |
| Absci Corporation | 73.66 Million USD | -1123.852% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -3168.662% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -574.873% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -272.297% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -244.045% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -333.456% |
| Allakos Inc. | 196.05 Million USD | -359.849% |
| Imunon, Inc. | 20.31 Million USD | -4338.915% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -694.545% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -144.583% |
| BioAtla, Inc. | 129.68 Million USD | -595.183% |
| NLS Pharmaceutics AG | 11.8 Million USD | -7535.789% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -5590.604% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -961.686% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -2059.017% |
| XOMA Corporation | 46.46 Million USD | -1840.388% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -710.969% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -532.84% |
| aTyr Pharma, Inc. | 12.97 Million USD | -6846.317% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -769.764% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -421.526% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -253.881% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -2310.079% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -10861.494% |
| Akari Therapeutics, Plc | 16.8 Million USD | -5264.527% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -39547.069% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -201.206% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -13298.702% |
| UroGen Pharma Ltd. | 138.88 Million USD | -549.129% |
| Sutro Biopharma, Inc. | 243 Million USD | -271.0% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -12293.255% |
| Orgenesis Inc. | 45.75 Million USD | -1870.327% |
| Entera Bio Ltd. | 8.86 Million USD | -10075.648% |
| GH Research PLC | 41.22 Million USD | -2087.091% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -3406.933% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -985.527% |
| Xencor, Inc. | 306.97 Million USD | -193.691% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -18173.905% |
| Replimune Group, Inc. | 234.77 Million USD | -284.015% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -4300.036% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -370.063% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -13298.702% |
| Portage Biotech Inc. | 18.19 Million USD | -4853.912% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -12319.03% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -758.95% |
| OncoCyte Corporation | 25.63 Million USD | -3416.646% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -14690.364% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -7769.055% |
| Purple Biotech Ltd. | -22.46 Million USD | 4112.83% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -5370.646% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1283.231% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -10565.925% |
| HilleVax, Inc. | 133.34 Million USD | -576.113% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -8665.799% |
| Tharimmune, Inc. | 9.45 Million USD | -9435.076% |
| Genprex, Inc. | 31.06 Million USD | -2802.595% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -380.767% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2773.323% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -117751.302% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -16451.787% |
| OKYO Pharma Limited | 8243.57 USD | -10936453.665% |
| Savara Inc. | 15.74 Million USD | -5626.024% |
| Curis, Inc. | 58.35 Million USD | -1444.962% |
| Daré Bioscience, Inc. | 33.6 Million USD | -2582.471% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -17603.772% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -11983.668% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -3236.402% |
| BeiGene, Ltd. | 3.28 Billion USD | 72.568% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -4421.535% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -80.759% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -486.756% |
| Erasca, Inc. | 141.52 Million USD | -537.034% |
| bluebird bio, Inc. | 240.23 Million USD | -275.288% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -19815.344% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 48.372% |
| DBV Technologies S.A. | 92.16 Million USD | -878.258% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -19815.344% |
| Moderna, Inc. | 6.39 Billion USD | 85.9% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -2015.897% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -6175.668% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -1251.648% |
| Travere Therapeutics, Inc. | 472 Million USD | -91.008% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -529.095% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -1352.212% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1976.663% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -333.173% |
| MacroGenics, Inc. | 217.21 Million USD | -315.055% |
| RenovoRx, Inc. | 11.39 Million USD | -7811.218% |
| Adicet Bio, Inc. | 152.03 Million USD | -492.985% |
| Prime Medicine, Inc. | 186.63 Million USD | -383.051% |
| Aditxt, Inc. | 25.95 Million USD | -3374.127% |
| Adagene Inc. | 41.83 Million USD | -2055.231% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -12233.11% |
| Quantum-Si incorporated | 111.65 Million USD | -707.425% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -424.622% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -6084.503% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -2416.784% |
| SciSparc Ltd. | 9.01 Million USD | -9905.132% |
| Vericel Corporation | 142.04 Million USD | -534.724% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -10314.664% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -3804.796% |
| Generation Bio Co. | 144.46 Million USD | -524.061% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -985.827% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -942.751% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -204.87% |
| Invivyd, Inc. | 205.75 Million USD | -338.173% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -1149.411% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -9513.073% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1098.026% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -8664.095% |
| 2seventy bio, Inc. | 289.88 Million USD | -211.005% |
| ADMA Biologics, Inc. | 66.58 Million USD | -1253.982% |
| Clene Inc. | 41.07 Million USD | -2095.025% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -6939.12% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1545.307% |
| GeoVax Labs, Inc. | 6.02 Million USD | -14870.717% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -156.091% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -2354.432% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -2573.039% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -769.378% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -2666.462% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -429.465% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -17.434% |
| Evaxion Biotech A/S | 22.27 Million USD | -3948.327% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -565.144% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -283.836% |
| Trevena, Inc. | 38.41 Million USD | -2247.024% |
| Surrozen, Inc. | 18.55 Million USD | -4760.175% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -1027.728% |
| Cingulate Inc. | 22.75 Million USD | -3861.312% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 12133.669% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1918.408% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -10849.343% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -779.076% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -19.557% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -1352.399% |
| Clearmind Medicine Inc. | 8.74 Million USD | -10213.767% |
| Kronos Bio, Inc. | 128.11 Million USD | -603.697% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -972.369% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -30638.734% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -794.168% |
| Statera Biopharma, Inc. | 28.82 Million USD | -3027.221% |
| ImmunityBio, Inc. | 362.87 Million USD | -148.452% |
| Korro Bio, Inc. | 84.53 Million USD | -966.509% |
| Kineta, Inc. | 21.15 Million USD | -4161.498% |
| BioVie Inc. | 31.95 Million USD | -2721.773% |
| Codexis, Inc. | 66.51 Million USD | -1255.366% |
| Celularity Inc. | 215.05 Million USD | -319.218% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -297.828% |
| Celcuity Inc. | 66.23 Million USD | -1261.253% |
| Virax Biolabs Group Limited | 6.54 Million USD | -13670.487% |
| Cibus, Inc. | 320.3 Million USD | -181.47% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1996.657% |
| IN8bio, Inc. | 30.33 Million USD | -2871.825% |
| Kodiak Sciences Inc. | 277.32 Million USD | -225.097% |
| Annexon, Inc. | 143.72 Million USD | -527.292% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -606.603% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -3835.407% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -140769.134% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -15.646% |
| Eyenovia, Inc. | 25.4 Million USD | -3448.558% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -542.527% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -16109.321% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -1039.3% |
| Arcellx, Inc. | 200.19 Million USD | -350.333% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1864.188% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -316.597% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -8954.559% |
| Moolec Science SA | 52.75 Million USD | -1609.103% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1374.635% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1837.178% |
| Royalty Pharma plc | 862.4 Million USD | -4.541% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -858.375% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -9565.26% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -3884.184% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -333.836% |
| Humacyte, Inc. | 23.49 Million USD | -3736.926% |
| 89bio, Inc. | 151.2 Million USD | -496.256% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -1025.097% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -6100.567% |
| Genelux Corporation | 24.33 Million USD | -3604.797% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -2557.673% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -421.529% |
| Notable Labs, Ltd. | 14.77 Million USD | -6004.011% |
| Liquidia Corporation | 87.98 Million USD | -924.689% |
| Mustang Bio, Inc. | 48.5 Million USD | -1758.853% |
| Immunovant, Inc. | 282.7 Million USD | -218.901% |
| Quantum-Si incorporated | 111.65 Million USD | -707.425% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -3899.124% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -4139.255% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -783.781% |
| Acasti Pharma Inc. | 11.3 Million USD | -7877.723% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -3833.329% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -5542.043% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1837.094% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -79362.22% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -5575.201% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2992.096% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -2078.529% |
| PepGen Inc. | 84.76 Million USD | -963.59% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2942.633% |
| United Therapeutics Corporation | 885.1 Million USD | -1.86% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -3837.47% |
| Solid Biosciences Inc. | 104.31 Million USD | -764.269% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -2654.921% |
| Immuneering Corporation | 58.41 Million USD | -1443.431% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -17611.604% |
| Silo Pharma, Inc. | 3.92 Million USD | -22888.158% |
| Belite Bio, Inc | 31.66 Million USD | -2746.919% |
| XOMA Corporation | 46.46 Million USD | -1840.388% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -1234.659% |
| Bionomics Limited | 17.89 Billion USD | 94.961% |
| Apogee Therapeutics, Inc. | 93 Million USD | -869.391% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2626.801% |
| uniQure N.V. | 285.08 Million USD | -216.242% |
| Cassava Sciences, Inc. | 105.95 Million USD | -750.876% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -12233.11% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -364.228% |
| Forte Biosciences, Inc. | 32.47 Million USD | -2676.003% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -10750.753% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2967.061% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -16109.321% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -6244.563% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -10042.451% |
| Altimmune, Inc. | 30.55 Million USD | -2850.525% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -110.817% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2626.801% |
| Compugen Ltd. | 43.97 Million USD | -1950.357% |
| Peak Bio, Inc. | 1249.13 USD | -72175130.52% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1116.355% |
| Benitec Biopharma Inc. | 22.38 Million USD | -3928.069% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -270.725% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -3058.611% |
| Zura Bio Limited | 62.63 Million USD | -1339.322% |
| PolyPid Ltd. | 21.04 Million USD | -4183.975% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -5439.214% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -3058.611% |
| Instil Bio, Inc. | 85.78 Million USD | -950.956% |
| argenx SE | 1.53 Billion USD | 41.21% |
| Immunome, Inc. | 122.82 Million USD | -634.052% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1759.927% |
| Verona Pharma plc | 67.15 Million USD | -1242.584% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -3382.953% |
| Shattuck Labs, Inc. | 93.61 Million USD | -863.064% |
| CervoMed Inc. | 14.95 Million USD | -5927.387% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -1175.14% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -10451.995% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1667.77% |
| Moolec Science SA | 52.75 Million USD | -1609.103% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -5381.143% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -580.142% |
| Design Therapeutics, Inc. | 78.19 Million USD | -1053.041% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -935.791% |
| NeurAxis, Inc. | 8.82 Million USD | -10120.407% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -7063.786% |
| Lumos Pharma, Inc. | 38.66 Million USD | -2231.728% |
| Achilles Therapeutics plc | 75.25 Million USD | -1098.01% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -3382.953% |
| 180 Life Sciences Corp. | 13.47 Million USD | -6589.389% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -3301.809% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -30638.734% |
| Nutriband Inc. | 5.73 Million USD | -15623.013% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -713.831% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1519.971% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1671.974% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -1263.958% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1565.763% |
| Palisade Bio, Inc. | 13.32 Million USD | -6668.487% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1885.427% |
| Beam Therapeutics Inc. | 554.19 Million USD | -62.68% |
| Neurogene Inc. | 55.58 Million USD | -1522.011% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -262.818% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1761.617% |
| Sesen Bio, Inc. | 78.38 Million USD | -1050.231% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -979.341% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -7062.707% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -99.906% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -925.785% |
| Athira Pharma, Inc. | 125.46 Million USD | -618.571% |
| Vaccinex, Inc. | 23.45 Million USD | -3743.796% |
| HCW Biologics Inc. | 21.02 Million USD | -4187.536% |
| XOMA Corporation | 46.46 Million USD | -1840.388% |
| Nektar Therapeutics | 190.9 Million USD | -372.262% |
| Arvinas, Inc. | 480 Million USD | -87.826% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -39547.069% |
| Merus N.V. | 200.49 Million USD | -349.671% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -772.297% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -2504.167% |
| Rezolute, Inc. | 70.38 Million USD | -1180.865% |
| Clene Inc. | 41.07 Million USD | -2095.025% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -5404.557% |
| BeyondSpring Inc. | 24.86 Million USD | -3525.829% |
| Synlogic, Inc. | 58.53 Million USD | -1440.29% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -4938.914% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -19970.402% |
| Peak Bio, Inc. | 1249.13 USD | -72175130.52% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1391.517% |
| Krystal Biotech, Inc. | 160.42 Million USD | -461.98% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -233.133% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -159.041% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -41702.209% |
| MannKind Corporation | 125.59 Million USD | -617.822% |
| Ikena Oncology, Inc. | 84.57 Million USD | -965.966% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -9245.521% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -906.197% |
| Gossamer Bio, Inc. | 183.75 Million USD | -390.622% |
| CohBar, Inc. | 12.38 Million USD | -7177.533% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1677.388% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -3168.662% |
| Legend Biotech Corporation | 583.14 Million USD | -54.603% |
| Mural Oncology plc | 192.07 Million USD | -369.39% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -1242.67% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -5484.065% |
| Disc Medicine, Inc. | 91.12 Million USD | -889.369% |
| Champions Oncology, Inc. | 28.11 Million USD | -3107.266% |
| REGENXBIO Inc. | 321.15 Million USD | -180.723% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -16716.324% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1516.978% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -2214.034% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -688.375% |
| Vaxart, Inc. | 90.72 Million USD | -893.72% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -10481.709% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -2006.746% |
| Cellectis S.A. | 97.32 Million USD | -826.39% |
| Longeveron Inc. | 21.25 Million USD | -4142.647% |
| Repare Therapeutics Inc. | 167.35 Million USD | -438.706% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 33.748% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1091.834% |
| Revolution Medicines, Inc. | 498.76 Million USD | -80.759% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -13453.254% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1951.15% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1108.691% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -1194.697% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -8051.559% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 81.119% |
| Denali Therapeutics Inc. | 527.23 Million USD | -71.0% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -10314.664% |
| Veru Inc. | 101.34 Million USD | -789.57% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -3751.679% |
| Cingulate Inc. | 22.75 Million USD | -3861.312% |
| Passage Bio, Inc. | 108.38 Million USD | -731.784% |
| Context Therapeutics Inc. | 25.07 Million USD | -3495.805% |
| Exicure, Inc. | 14.07 Million USD | -6304.962% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -337.516% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1982.082% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -9723.842% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -257.078% |
| Nuvalent, Inc. | 149.49 Million USD | -503.084% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -11076.068% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -769.814% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -4103.284% |
| OmniAb, Inc. | 83.89 Million USD | -974.632% |
| Anew Medical, Inc. | 1.3 Million USD | -69206.123% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -2651.686% |
| Lipocine Inc. | 15.08 Million USD | -5878.476% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -1215.9% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1083.899% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2136.334% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -685.039% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -3927.709% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -35.748% |
| Ocugen, Inc. | 71.56 Million USD | -1159.746% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -860.478% |
| Q32 Bio Inc. | 92.68 Million USD | -872.769% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -4157.875% |
| Alumis Inc. Common Stock | 158.17 Million USD | -469.981% |
| Equillium, Inc. | 50.6 Million USD | -1681.533% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -1344.673% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -6383.47% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -4678.994% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -1820.22% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -731.194% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -7174.932% |
| Dominari Holdings Inc. | 23.83 Million USD | -3682.515% |
| Edesa Biotech, Inc. | 9.22 Million USD | -9675.411% |
| vTv Therapeutics Inc. | 11.9 Million USD | -7471.701% |
| Bio-Techne Corporation | 563.03 Million USD | -60.124% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -120.536% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -235.458% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -581.572% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -6156.071% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -450.754% |
| Nkarta, Inc. | 131.65 Million USD | -584.818% |
| BioCardia, Inc. | 12.12 Million USD | -7338.02% |
| Iterum Therapeutics plc | 47.46 Million USD | -1799.306% |